Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma

• Kazuma Ohyashiki ,

  * E-mail: ohyashik@rr.iij4u.or.jp

  Affiliation Hematology Division, First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan

  ⨯
• Tomohiro Umezu,

  Affiliation Hematology Division, First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan

  ⨯
• Sei-ichiro Yoshizawa,

  Affiliation Hematology Division, First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan

  ⨯
• Yoshikazu Ito,

  Affiliation Hematology Division, First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan

  ⨯
• Michiyo Ohyashiki,

  Affiliation Hematology Division, First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan

  ⨯
• Hisashi Kawashima,

  Affiliation Department of Pediatrics, Tokyo Medical University, Tokyo, Japan

  ⨯
• Masami Tanaka,

  Affiliation Department of Molecular Pathology, Tokyo Medical University, Tokyo, Japan

  ⨯
• Masahiko Kuroda,

  Affiliation Department of Molecular Pathology, Tokyo Medical University, Tokyo, Japan

  ⨯
• Junko H. Ohyashiki

  Affiliation Intractable Disease Research Center, Tokyo Medical University, Tokyo, Japan

  ⨯